These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8240042)

  • 1. [Cardiovascular dysfunction in septic shock and its treatment].
    Dias FS
    Arq Bras Cardiol; 1993 Jan; 60(1):43-9. PubMed ID: 8240042
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiology of cardiovascular dysfunction in septic shock.
    Parker MM
    New Horiz; 1998 May; 6(2):130-8. PubMed ID: 9654320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular dysfunction in human septic shock.
    Parrillo JE
    Prog Clin Biol Res; 1989; 308():191-9. PubMed ID: 2675047
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of endotoxin in human septic shock: therapeutic potential of lipid A analogs.
    Danner RL; Parrillo JE
    Prog Clin Biol Res; 1989; 286():183-200. PubMed ID: 2648410
    [No Abstract]   [Full Text] [Related]  

  • 5. Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock.
    Beutler B
    New Horiz; 1993 Feb; 1(1):3-12. PubMed ID: 7922391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The endotoxic shock. Pathogenesis and therapy].
    Cremer H
    Arch Kinderheilkd; 1971; 182(3):209-17. PubMed ID: 4928617
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of heart performance during septic shock in sheep.
    Newald J; Sugi K; Vogl C; Krösl P; Traber DL; Schlag G
    Prog Clin Biol Res; 1989; 308():237-45. PubMed ID: 2780698
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenetic mechanisms of septic shock.
    Parrillo JE
    N Engl J Med; 1993 May; 328(20):1471-7. PubMed ID: 8479467
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular management of septic shock.
    Pravinkumar E
    Crit Care Med; 2004 Jan; 32(1):315; author reply 315. PubMed ID: 14707616
    [No Abstract]   [Full Text] [Related]  

  • 10. An appraisal of selection and use of catecholamines in septic shock - old becomes new again.
    Myburgh JA
    Crit Care Resusc; 2006 Dec; 8(4):353-60. PubMed ID: 17227275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport.
    Morelli A; Lange M; Ertmer C; Broeking K; Van Aken H; Orecchioni A; Rocco M; Bachetoni A; Traber DL; Landoni G; Pietropaoli P; Westphal M
    Shock; 2007 Nov; 28(5):530-5. PubMed ID: 17589379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiocirculatory changes in various forms of shock].
    Larsen R
    Klin Anasthesiol Intensivther; 1987; 33():1-18. PubMed ID: 3312774
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of tumor necrosis factor-alpha in endotoxin shock.
    Billings RE; Chen SA; Hollenbach S; Amman A; Patzer E; Hobson W; McCalden TA
    Proc West Pharmacol Soc; 1990; 33():117-21. PubMed ID: 2274521
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of septic cardiovascular failure].
    Reinelt H; Lindner KH
    Klin Anasthesiol Intensivther; 1995; 47():139-53. PubMed ID: 7715171
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathophysiology and management of septic shock.
    Duff P
    J Reprod Med; 1980 Mar; 24(3):109-17. PubMed ID: 6989991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma concentration of tumor necrosis factor correlated with gravity of septic shock].
    Romieu M; Bousseau A; Riche F; Payen D
    Ann Fr Anesth Reanim; 1989; 8 Suppl():R238. PubMed ID: 2604196
    [No Abstract]   [Full Text] [Related]  

  • 18. Circadian time structure of septic shock: timing is everything.
    Hrushesky WJ; Wood PA
    J Infect Dis; 1997 May; 175(5):1283-4. PubMed ID: 9129107
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamics in patients with septic shock and acute lung lesion].
    Suborov EV; Kuz'kov VV; Smetkin AA; Kirov MIu
    Anesteziol Reanimatol; 2006; (6):15-20. PubMed ID: 17288259
    [No Abstract]   [Full Text] [Related]  

  • 20. Sublingual microcirculatory flow is impaired by the vasopressin-analogue terlipressin in a patient with catecholamine-resistant septic shock.
    Boerma EC; van der Voort PH; Ince C
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1387-90. PubMed ID: 16146482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.